{"id":"W4417014736","doi":"10.1182/blood-2025-3895","title":"Preliminary efficacy and safety of the Bruton tyrosine kinase degrader BGB-16673 in patients with relapsed/refractory Richter transformation: Results from the ongoing phase 1 CaDAnCe-101 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Bruton's tyrosine kinase; Ibrutinib; Chemoimmunotherapy; Tolerability; Chronic lymphocytic leukemia; Phases of clinical research; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263278,0.0006069572,0.00124307,0.0002028567,0.0002645136,0.0008377235,0.0005629272,0.0006522195,0.001628824],"category_scores_gemma":[0.0007987699,0.0002134084,0.001112569,0.0002420352,0.0004123381,0.0004311128,0.0002452411,0.001704907,0.0005913025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007477696,"about_ca_system_score_gemma":0.0006454226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009820242,"about_ca_topic_score_gemma":0.002695417,"domain_scores_codex":[0.9994034,0.0003331042,0.0000414516,0.00007876234,0.00007193023,0.00007133944],"domain_scores_gemma":[0.9993083,0.000149916,0.0001583748,0.00007972811,0.00007117588,0.0002325627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4482176,0.03505751,0.04582411,0.002076116,0.004330634,0.0009530051,0.0006878754,0.005025997,0.1496225,0.0003834241,0.009335544,0.2984857],"study_design_scores_gemma":[0.2075992,0.6357936,0.1196054,0.0001657304,0.002647148,0.001717395,0.00019094,0.002628655,0.0180801,0.0003247136,0.01116538,0.00008184751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895857,0.004850766,0.0005060468,0.0002589177,0.00003834042,0.0007614954,0.001296333,0.00007692933,0.002625463],"genre_scores_gemma":[0.9922796,0.001728925,0.000765474,0.0006787897,0.00004498983,0.000340918,0.003055091,0.00002126969,0.001084904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00263278,"threshold_uncertainty_score":0.01392365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01228521462498295,"score_gpt":0.2723958621389367,"score_spread":0.2601106475139537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}